Alerts will be sent to your verified email
Verify EmailSOTAC
|
Sotac Pharmaceutical
|
Lactose India
|
Accretion Nutraveda
|
|
|---|---|---|---|
|
Operational Metrics
|
|||
|
Financials
|
|||
|
5 yr Average ROE
|
-2.41 % | 5.07 % | 77.09 % |
|
5yr average Equity Multiplier
|
5.52 | 2.35 | 7.25 |
|
5yr Average Asset Turnover Ratio
|
1.27 | 0.71 | 1.09 |
|
5yr Avg Net Profit Margin
|
3.04 % | 2.1 % | 14.14 % |
|
Price to Book
|
2.46 | 2.05 | 23.93 |
|
P/E
|
16.29 | 28.28 | 48.96 |
|
5yr Avg Cash Conversion Cycle
|
57.86 Days | 55.42 Days | 88.82 Days |
|
Inventory Days
|
44.94 Days | 72.49 Days | 125.44 Days |
|
Days Receivable
|
113.65 Days | 58.07 Days | 40.1 Days |
|
Days Payable
|
123.13 Days | 151.0 Days | 182.51 Days |
|
5yr Average Interest Coverage Ratio
|
3.95 | 1.65 | 5.76 |
|
5yr Avg ROCE
|
21.68 % | 11.65 % | 50.7 % |
|
5yr Avg Operating Profit Margin
|
8.59 % | 18.59 % | 23.04 % |
|
5 yr average Debt to Equity
|
2.1 | 1.02 | 3.41 |
|
5yr CAGR Net Profit
|
n/a | n/a | 56.28 % |
|
5yr Average Return on Assets
|
3.18 % | 2.34 % | 16.23 % |
|
Shareholdings
|
|||
|
Promoter Holding
|
72.85 % | 53.65 % | n/a |
|
Share Pledged by Promoters
|
0.0 | 26.07 % | n/a |
|
Change in Promoter Holding (3 Yrs)
|
0.0 | -0.14 % | n/a |
|
Change in Mutual Fund Holding (3 Yrs)
|
0.0 | 0.0 | n/a |
|
Sotac Pharmaceutical
|
Lactose India
|
Accretion Nutraveda
|
|
|---|---|---|---|
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
|
Location Wise Break-Up
|
Location Wise Break-Up
|
-
|
Location Wise Break-Up
|